MoneyMe Limited (MME.AX)
AUD 0.17
(-2.86%)
AUD 0.17
(-2.86%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 71.49 Million | 238.87 Million | 143.07 Million | 57.07 Million | 47.27 Million | 31.89 Million |
| Cost of Revenue | 20.74 Million | 17.27 Million | 4.53 Million | 1.68 Million | 985 Thousand | 231 Thousand |
| Gross Profit | 50.74 Million | 221.59 Million | 138.54 Million | 55.38 Million | 46.28 Million | 31.66 Million |
| Operating Expenses | 52.88 Million | 51.96 Million | 56.81 Million | 25.37 Million | 18.08 Million | 10.02 Million |
| Selling, General and Administrative Expenses | 48.15 Million | 51.96 Million | 56.81 Million | 26.57 Million | 15.68 Million | 0.01 |
| Research and Development Expenses | 4.72 Million | 8.57 Million | 6.62 Million | 3.64 Million | 2.71 Million | - |
| Other Expenses | - | -51.96 Million | -56.81 Million | -25.37 Million | -18.08 Million | 169.4 Million |
| Cost and Expenses | 52.88 Million | 136.78 Million | 152.36 Million | 55.31 Million | 34.63 Million | 31.66 Million |
| Operating Income | 18.6 Million | 169.63 Million | 81.72 Million | 30.01 Million | 28.2 Million | 125 Thousand |
| Interest Expense | - | 89.8 Million | 38.49 Million | 10.59 Million | 12.75 Million | 8.54 Million |
| Income Tax Expense | -10.33 Million | 180.97 Million | 2.58 Million | -2.1 Million | -1.41 Million | 20.75 Million |
| Earnings before Tax | 12.38 Million | 12.28 Million | -47.78 Million | -10.03 Million | -119 Thousand | 231 Thousand |
| Net Income | 22.72 Million | 12.28 Million | -50.36 Million | -7.92 Million | 1.29 Million | 20.51 Million |
| Earnings Per Share Basic | 0.03 | 0.04 | -0.26 | -0.05 | 0.01 | 63.33 |
| Earnings Per Share Diluted | 0.03 | 0.04 | -0.26 | -0.05 | 0.01 | 10.79 Billion |
| Weighted Average Shares Outstanding | 795.07 Million | 321.35 Million | 190.8 Million | 169.44 Million | 154.3 Million | 324 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 795.07 Million | 321.35 Million | 190.8 Million | 169.44 Million | 154.3 Million | 0.00 |
| Gross Margin | 0.71 | 0.93 | 0.97 | 0.97 | 0.98 | 0.99 |
| EBIT Margin | 1.70 | 0.76 | 0.59 | 0.56 | 0.62 | 0.73 |
| Profit Margin | 0.32 | 0.05 | -0.35 | -0.14 | 0.03 | 0.64 |
| EBITDA | 121.8 Million | 180.97 Million | -7.05 Million | 31.7 Million | 29.19 Million | 8.54 Million |
| Earnings Before Tax Margin | 0.26 | 0.71 | 0.57 | 0.53 | 0.60 | 0.00 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 214.14 Million | 34.76 Million | 107.51 Million | 117.78 Million | 238.87 Million | 121.09 Million |
| Cost of Revenue | 20.74 Million | 10.73 Million | 10 Million | 9.38 Million | 17.27 Million | 7.89 Million |
| Gross Profit | 193.4 Million | 24.03 Million | 97.5 Million | 108.4 Million | 221.59 Million | 113.19 Million |
| Operating Expenses | -48.15 Million | 52.88 Million | 30.55 Million | 29.12 Million | 51.96 Million | 34.17 Million |
| Selling, General and Administrative Expenses | - | 48.15 Million | 5.63 Million | 23.81 Million | - | 6.03 Million |
| Research and Development Expenses | - | 4.72 Million | - | 3.47 Million | - | 5.09 Million |
| Other Expenses | -48.15 Million | 0.06 | 0.06 | 0.03 | -51.96 Million | 0.07 |
| Cost and Expenses | 103.28 Million | 52.88 Million | 51.67 Million | 66.47 Million | 136.78 Million | 70.31 Million |
| Operating Income | 145.24 Million | -18.12 Million | 72.59 Million | 84.58 Million | 169.63 Million | 85.04 Million |
| Interest Expense | - | - | 49.66 Million | 47.82 Million | 89.8 Million | 41.98 Million |
| Income Tax Expense | -10.33 Million | 10.33 Million | 0.01 | - | 180.97 Million | 0.03 |
| Earnings before Tax | 12.38 Million | 6.21 Million | 6.17 Million | 3.48 Million | 12.28 Million | 8.79 Million |
| Net Income | 22.72 Million | 16.55 Million | 6.17 Million | 3.48 Million | 12.28 Million | 8.79 Million |
| Earnings Per Share Basic | - | 0.02 | 0.01 | 0.00 | - | 0.03 |
| Earnings Per Share Diluted | - | 0.02 | 0.01 | 0.00 | - | 0.03 |
| Weighted Average Shares Outstanding | 795.07 Million | 795.1 Million | 795.07 Million | 759.41 Million | 321.35 Million | 261.52 Million |
| Weighted Average Shares Outstanding (Diluted) | 795.07 Million | 795.07 Million | 795.07 Million | 759.41 Million | 321.35 Million | 267.26 Million |
| Gross Margin | 0.90 | 0.69 | 0.91 | 0.92 | 0.93 | 0.93 |
| EBIT Margin | - | 2.24 | 0.73 | 0.76 | - | 0.75 |
| Profit Margin | 0.11 | 0.48 | 0.06 | 0.03 | 0.05 | 0.07 |
| EBITDA | - | 77.96 Million | 78.22 Million | 89.89 Million | - | 91.07 Million |
| Earnings Before Tax Margin | 0.68 | -0.52 | 0.68 | 0.72 | 0.71 | 0.70 |
WOCKPHARMA
603390
0L8B
RSMXF
QYBX
FSC